Flow cytometry to distinguish myelodysplastic syndromes from non-neoplastic causes of cytopenia: ready for prime time?
Robert P
RP
Hasserjian
Frederic I
FI
Preffer
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D005260:Female; D005434:Flow Cytometry / Q000379:methods*; D006412:Hematopoietic Stem Cells / Q000473:pathology*; D006801:Humans; D008297:Male; D009190:Myelodysplastic Syndromes / Q000175:diagnosis*; D010198:Pancytopenia / Q000139:chemically induced*